Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Total Voting Rights

1st Dec 2021 16:15

RNS Number : 2739U
Ideagen PLC
01 December 2021
 

Ideagen PLC

 

("Ideagen," "the Company" or the "Group'')

Total Voting Rights

In line with the Financial Conduct Authority's Disclosure and Transparency Rules, Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that as at today's date, the Company's total issued share capital is 255,351,615 ordinary shares of 1p each ("Ordinary Shares") and the total number of voting rights will therefore be 255,351,615.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

Enquiries:

Ideagen plc

01629 699 100

Ben Dorks, Chief Executive Officer

Emma Hayes, Chief Financial Officer

finnCap Limited

020 7220 0500

Henrik Persson / James Thompson (Nomad)

Alice Lane (ECM)

 

Canaccord Genuity

020 7523 8000

Simon Bridges

Georgina McCooke

 

 

Numis Securities Limited

020 7260 1000

Simon Willis

Joshua Hughes

 

FTI Consulting

020 3727 1000

Jamie Ricketts

[email protected]

Dwight Burden

Valerija Cymbal

 

About Ideagen plc

Ideagen's software helps companies comply with regulation and manage risk.

 

Ideagen is a leader in the +$30 billion regulatory and compliance software market, serving highly regulated industries such as life sciences, healthcare, banking and finance and insurance. Ideagen has made 24 acquisitions since admission to AIM to build its market leadership.

 

More than 7,500 customers use Ideagen's software, including nine of the top 10 UK accounting firms, 7 of the top global aerospace and defence companies and 75% of leading pharmaceutical firms.

 

Ideagen has a diversified customer base including blue chip, global brands such as Heineken, British Airways, BAE, Aggreko, US Navy, Bank of New York and Johnson Matthey, as well as 250 hospitals across the UK and US.

 

Ideagen is headquartered in the UK, listed on the London Stock Exchange AIM market (Ticker: IDEA.L), and has key hubs in the UK, EU, US, South East Asia and Australia. For further information please visit www.ideagen.com .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRTBBFTMTBMBIB

Related Shares:

IDEA.L
FTSE 100 Latest
Value8,275.66
Change0.00